on rodent bioassay data" (from the GALAS website 1). To obtain reproducible data within and between laboratories worldwide, an outbred strain of rodent species should be developed. To this end, a consortium, the Global Alliance for Laboratory Animal Standardization (GALAS), was established by major animal breeders in Japan, Europe and the USA. By this consortium, Wistar Hannover (WH) GALAS rats have been bred and distributed for global use not only in toxicology but also in biomedical sciences. It has been shown that the physiological characteristics of this rat strain are stable over time (from the GALAS website 2). Although WH rats have been extensively used in the risk assessment of various chemicals, a substrain of WH rats, named Han/Wistar (Kuopio), has toxicities caused by dioxins (Pohjanvirta et al., 1993) . In addition, between Long-Evans (L-E) and Han/Wistar (Kuopio) rat strains, there is a difference in susceptibiland reproductive disorders, depending on the different aryl hydrocarbon receptor (AhR) sequence (Pohjanvirta and Tuomisto, 1994; Viluksela et al., 2000; Simanainen et al., 2002 Simanainen et al., , 2004 . However, it is not known whether there is a difference in the transactivation activity depending on the AhR sequence among rat strains.
Among 75 dioxin congeners having the different numbers of chlorine atoms and their positions on benzene rings, the most potent congener is 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). TCDD has been reported to exert various toxicities in humans and laboratory animals, and there are considerable differences in the sensitivity to TCDD toxicities among animal species and strains (Pohjanvirta and Tuomisto, 1994) . Such differences in sensitivity are attributable to AhR polymorphism.
AhR is a nuclear transcription factor that activates various genes having a motif called the xenobiotic response element (XRE, also termed dioxin response element (DRE) or AhR response element (AhRE)) (Fujisawa-Sehara et al., 1988; Whitlock, 1999; Okey, 2007) and binds aromatic cyclic hydrocarbons including dioxins. AhR consists of basic helix-loop-helix (bHLH) and PER-ARNT-SIM (PAS) domains and a glutaminerich domain. The PAS and glutamine-rich domains act in ligand binding and transactivation domains, respectively. The manifestation of TCDD toxicities can be altered by the binding affinity of AhR for TCDD and by the polymorphism in the transactivation domain Moriguchi et al., 2003) . Among mice, the C57BL/6 mouse, the strain most susceptible to TCDD toxicities, has been shown to have a point mutation from valine to alanine at codon 375 in the ligand binding domain, as well as deletion of 43 amino acid residues in the C-ter--ty for TCDD to enhance the induction of CYP1A1 and to exert various kinds of toxicity including lethality. The DBA/2 strain, the less sensitive strain, has a reduced binding affinity for TCDD (Ema et al., 1994) . Humanized AhR knock-in mice, whose own AhRs were replaced with human AhRs, were found to be less sensitive to the teratogenicity of TCDD than DBA/2 mice (Moriguchi et al., 2003) .
Among rats, the Han/Wistar (Kuopio) strain is at least 1000-fold less sensitive to the acute lethal effects of TCDD than most other rat strains (Pohjanvirta and Tuomisto, 1994) . Such resistance is attributable to a marked difference in the AhR sequence. The structures of the mutant mRNA and AhR are shown in Fig. 1 . There are two types of mutation in the AhR gene. One is a point mutation in exon 10, in which a transition mutation at the second base of the codon causes an amino acid shift from valine to alanine at codon 497 (nucleotide 1520) in a hypervariable region, and it is considered that this change cannot be attributable to the large strain difference in susceptibility as has been found in the Han/ Wistar (Kuopio) strain (Pohjanvirta et al., 1998) . The other one is a point mutation at nucleotide 2454 in AhR's glutamine-rich domain, which is involved in transactivation; this has been considered to be responsible for the above-mentioned large strain difference in susceptibility. This AhR genotype named AhR hw/hw has been transcribed to make three splicing variants (named AhRdv, shorter insertion variant (siv), and longer insertion variant (liv)), but shown to produce two types of AhR --pared with the wild-type AhR (AhR-WT) expressed by Sprague-Dawley or L-E rats (Pohjanvirta et al., 1998) (Fig. 1) .
However, to our knowledge, no information is available on the types of AhR genotype the WH GALAS strain has. Because the induction of CYP1A1, CYP1A2, or CYP1B1, Phase I of the drug-metabolizing enzymes, by drugs or environmental chemicals depends on the AhR genotype, it is worthwhile studying the AhR genetype present in the WH GALAS strain. In this study, we found that this strain consists of mixed subpopulations in terms of AhR genotype (AhR wt/wt , AhR wt/hw and AhR hw/hw ), and we further compared possible differences in susceptibility to TCDD toxicities with L-E strain, having AhR wt/wt , that has been known to be highly sensitive to TCDD (Pohjanvirta and Tuomisto, 1994) . Furthermore, we transfected wildtype or mutated AhR cDNA to cultured T cells and evalu-
MATERIALS AND METHODS

Reagents
TCDD (purity, > 99.5%) was purchased from Cambridge Isotope Laboratories (Andover, MA, USA). Corn oil and dimethyl sulfoxide (DMSO) used to dissolve dioxin compounds for in vivo and in vitro experiments were obtained from Sigma (St. Louis, MO, USA) and AhR hw/hw , and their corresponding mRNA and protein are described. The size of PCR products of AhR variants that were determined by RT-PCR using a common primer is described. See also the agarose gel electrophoresis data for these AhR variants in Fig. 2A all the other reagents were purchased from Wako Pure Chemical Industries (Osaka, Japan).
Animals
Female WH GALAS and L-E rats were purchased from CLEA Japan (Tokyo, Japan) and Charles River Laboratories International (Wilmington, MA, USA), respectively. The rats were 6 weeks old at the beginning of the experiment. Both rat strains were housed in the vivarium of the Shin Nippon Biomedical Laboratories (SNBL), and handled humanely according to the guidelines for animal experiments of the SNBL. The animals were maintained in a controlled environment at a temperature of 22 ± 2°C and a humidity of 50 ± 10% in a 12/12-hr light/ dark cycle, and given food (CE-2, CLEA Japan) and distilled water ad libitum. The animals were housed individually in stainless steel cages during the experimental period. Animals were anesthetized with diethyl ether prior to terminal euthanasia.
Administration of TCDD and collection of tissues
The experimental procedure, from TCDD administration to necropsy, was performed in a laboratory designated for the handling of hazardous chemicals and segregated from other laboratory areas. In the toxicity examinations, WH GALAS-AhR wt/wt , WH GALAS-AhR hw/hw , and L-E rats were gavaged a single oral dose of TCDD anesthesia 168 hr after the TCDD administration. The liver and thymus samples were weighed, soaked immediately in liquid nitrogen, and maintained at -80°C until analyses. The handling of TCDD and disposal of the waste were performed according to the guidelines of the SNBL and National Institute for Environmental Studies.
Determination of AhR allele in WH GALAS rats
Genomic DNA was extracted from a piece of ear tissue of WH GALAS rats using the Wizard SV 96 Genomic -priate primers (forward, 5'-TCACA GTCAG CCATG GTCAG TC-3'; reverse, 5'-TGCCC ACAGA AACTT ACTGG TG-3') to yield a 437-nucleotide product. The PCR parameters were as follows: 94°C for 20 sec and 72°C for 1 min (5 cycles), 94°C for 20 sec and 70°C for 1 min (5 cycles) and 94°C for 20 sec and 68°C for 1 min -tridge column and subjected to direct sequencing to determine the base sequence of the boundary region between exon 10 and intron 10 in which the point mutation, i.e., wild-type (ggt) and mutation (gat), is present. The forward and reverse primers used for the direct sequencing of the AhR allele were 5'-ATGGT CAGTC CTCAG GCGTA-3' and 5'-GTCCC AAAGT TGCTT GCTGC-3', respectively.
Real-time RT-PCR
Total RNAs were purified from liver and thymus specimens with the RNeasy Mini kit (QIAGEN, were reverse-transcribed using SuperScript II RNase H-Reverse Transcriptase and an oligo(dT)12-18 primer. SYBR Green real-time assays were used to quantify the CYP1A1 rat mRNAs (forward primer 5'-TTTGT CCCAT TCACC ATCCC-3', reverse primer 5'-GTCTC CCCAA TGCAC TTTCG-3') with a real-time RT-PCR apparatus (Roche Molecular Systems, Alameda, CA, USA) according to the manufacturer's instructions. The PCR program was 95°C for 15 min, followed by 40 cycles of 95°C for 15 sec, 60°C for 20 sec, and 72°C for 10 sec. The relative amount of cyclophilin (CP; forward primer 5'-GGAAT GGCAA GACCA GCAAG-3', reverse primer 5'-AGGGT ATTGC GAGCA GATGG-3') mRNA as the internal control was also determined to
Western blotting
The thymus specimens were homogenized in 2.5 volumes of ice-cold buffer (1.0% Triton X-100, 0.2 mM phenylmethansulfonylfluoride, 25 μg/ml leupeptin and 10 mM EDTA, pH 7.3), and the homogenate was centrifuged at 20,000 × g for 15 min. The supernatant fraction was mixed with one volume of buffer (0.125 M Tris-HCl (pH 6.8), 10% 2-mercaptoethanol (2-ME), 4.0% SDS, 10% sucrose and 0.004% bromophenol blue). SDS-PAGE was carried out using Excel Gel SDS Homogeneous 8-18 (Amersham Bioscience, Piscataway, NJ, USA). Dena--ferred to Hybond C + cellulose membranes, blocked overnight with 10% blocking agent (Amersham Bioscience), and probed with anti-AhR (No. SA-210; BIOMOL, Plymouth Meeting, PA, USA) (1:1000 dilution) or antiactin (Sigma) (1:200 dilution). Antibody binding was -nescence using ECL Plus (Amersham Bioscience).
Plasmid constructs
The rat wild-type AhR expression plasmid pCI-AhRwt was generated by cloning the open reading frame (ORF) of Sprague-Dawley rat AhR (sequence in the public datapfx DNA polymerase (Invitrogen), into the XhoI (forward; AACTC GAGAT GAGCA GCGGC GCCAA CAT-CA CCT) and MluI (reverse; CCACG CGTTA CAGGA ATCCG CTGGG TGTGA TATC) sites of the pCI-neo Mammalian Expression vector (Clontech, Palo Alto, CA, USA). In addition, by cloning the ORFs of WH GALAS rat AhR (sequence in the public database AF082124 (dv), AF082125 (siv), and AF082126 (liv), we generated three expression plasmids for the WH GALAS AhR, namely, pCI-AhRdv, pCI-AhRsiv, and pCI-AhRliv, respectively. An Epstein-Barr-virus-based expression vector that contains a multicloning site, pEB6-CAGMCS, was kindly provided by Dr. Y. Miwa (University of Tsukuba) (Tanaka et al., 1999) . The above-described four pCI-AhR variants were subcloned into the XhoI-or NotI restriction site of the pEB6-CAGMCS vector to generate pEB6-CAG-AhRwt, pEB6-CAG-AhRdv, pEB6-CAG-AhRsiv and pEB6-CAG-AhRliv.
The pIRES-hrGFP-1a vector (Stratagene, La Jolla, CA, USA) encoding hrGFP was used as a template for PCR with the following primers to create an XhoI-EcoRI site: forward, 5'-AACTC GAGCG CCACC ATGGT GAGCA AGCAG ATCCT GAA-3'; reverse, 5'-GGGGG GAATT CGGGA TTTTG CCCAT TTCGG CCTAT TGG-3'. The
XhoIEcoRI site of the pEB6-CAGMCS vector and designated pEB6-CAG-hrGFP. The 5'flanking region of the rat CYP1A1 promoter spanning 1,570 bp above the starting Taq (TaKaRa Bio) with appropriate primers (forward, AAACG CGTTG TGACC AGAGT GGGAG GTGAG GG; reverse, TACTC GAGCC CCTTC ATGGT TAG-GG TGAAG GC), inserted into the pGL3-Basic vector (Promega) using MluI and XhoI sites, and designated prCYP1A1-Luc. Another reporter plasmid, pX4TK-Luc, that includes the thymidine kinase (TK) promoter, four tandem copies of XRE motifs and the luciferase gene (Mimura et al., 1999) , was kindly provided by Dr. K. Sogawa (Tohoku University).
Cell culture and transfection
HeLa cells (American Type Culture Collection, Rockville, MD, USA) and Jurkat T cells (Cell Resource Center for Biomedical Research, Tohoku University) were cultured in MEM (Invitrogen) and RPMI 1640 (Invitrogen), respectively. Both media contained 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, and 0.1% 2-ME. They were cultured in an incubator supplemented with 5% CO 2 at 37°C.
To evaluate the effects of the AhR variants on transcriptional activity, we cotransfected each of the AhR constructs with prCYP1A1-Luc or pX4TK-Luc into HeLa cells by a liposome method, as described previously (Shiizaki et al., 2005) , and performed a reporter assay to determine luciferase activity. In brief, we used either of the AhR variants (0.5 μg/well), prCYP1A1-Luc or pX4TK-Luc (0.4 μg/well), pRL-SV40 (Promega) control vector (10 ng/well) and SuperFect Transcription Regent (QIAGEN; 4.5 μl/well) in HeLa cells cultured in a sixwell plate. The cells were divided into 48 wells in a multiwell plate 24 hr after transfection, and TCDD (0, 0.01, 0.1 and 1.0 nM/well) was added to the medium. Eighteen hours after the TCDD exposure, reporter assays were conducted using the Dual-Luciferase Reporter Assay System (Promega) in a Wallac Arvo SX Multi-Label counter (Perkin-Elmer, Boston, MA, USA). All the reporter assay experiments were performed in triplicate.
To determine whether and how the AhR structure mediates TCDD actions on human T cell growth, Jurkat T cells (1 × 10 5 cells) were transiently cotransfected with 1.5 μg of pEB6-CAG-hrGFP and 3 μg of either of the four pEB6-CAG-AhR variants using the TransITJurkat Transfection Reagent (Mirus, Madison, WI, USA) according to manufacturer's instructions (Ito et al., 2004) . They were cultured for 48 hr, followed by further maintenance in a medium containing 10 nM TCDD for 96 hr. The total number of live cells was estimated in an aliquot of the specimens stained with trypan blue, and the percentage of GFP-positive cells was determined using FACSCalibur (BD Biosciences, San Jose, CA). The growth rate was expressed as the percentage of GFP-positive cells relative to the total number of live cells at the start of the TCDD exposure.
Statistical analysis
Possible differences among L-E, WH GALASAhR wt/wt and WH GALAS-AhR hw/hw rat strains or TCDD dose by group were examined by two-way analysis of variance with Fisher's PLSD test, and the possible effects of TCDD dose on the mean body, liver and thymus weights among each rat strain were examined using ANOVA with Fisher's PLSD test. CYP1A1 mRNA expression level analysis, reporter gene assay and cell growth test results examined by one-way ANOVA with Fisher's PLSD test. All the statistical analyses were performed using StatView for Windows, version 5.0 (SAS Institute, Cary, NC, USA) or Excel Statistics 2006 for Windows (Social Survey Research Information Co., Tokyo, Japan). Differ-P value was less than 0.05.
RESULTS
GALAS rat and protein levels
We found that the WH GALAS rat consists of substrains having three different AhR alleles, AhR wt/wt AhR wt/hw and AhR hw/hw , and determined the frequency of each AhR allele in 243 rats using a direct-sequencing method. (Kawakami et al., 2006; Pohjanvirta et al., 1998) .
The RT-PCR analysis results of the boundary region containing exon 10 and its intron adjacent to exon 11 of the liver samples showed one band (566 bp) for the AhR wt/wt genotype, and three bands (437, 595, and 700 bp) for the AhR hw/hw genotype (Fig. 1) . On the other hand, AhR wt/hw liver specimens had a mixture of these bands ( Fig. 2A) . By immunoblot analysis, we were able bands are specific to AhR wt/wt and AhR hw/hw genotypes. Because of their similar molecular sizes, we failed to difAhR mRNA and protein in WH GALAS strain are consistent with the data reported for Han/Wistar (Kuopio) rats (Pohjanvirta et al., 1998) .
Changes in body and organ weights upon TCDD administration
A single oral administration of TCDD to most of the rat strains could result in a dose-dependent decrease in thymus weight around one week (Tuomisto et al., 1999) . When the three strains of rats, L-E (AhR wt/wt ) and WH GALAS (AhR wt/wt and AhR hw/hw ) were administered TCDD 168 hr post-administration, compared with the respective rat strains given vehicle, but TCDD increased the liver weight of these three rat strains remarkably although no -es (Table 1) . tion of the boundary region containing exon 10 and its intron adjacent to exon 11 of AhR mRNA in the WH GALAS rat. RT-PCR was performed with total RNA from the liver. The size of each AhR PCR product of WH GALAS-AhR wt/wt , AhR wt/hw and AhR hw/hw in the agarose gel is shown in Fig. 1A. ( Thymus weight decreased in a dose-dependent manner in the three rat strains, and this decrease trend was obvious in L-E and WH GALAS rats having the AhR wt/wt allele. In these rat strains, the thymus weights 168 hr after TCDD administration at 5 and 10 μg/kg were approximately 68-73% and 56-57%, respectively. In contrast, WH GALAS rats having AhR hw/hw were more resistant to TCDD exposure than L-E and WH GALAS rats having the AhR wt/wt allele, and their thymus weights decreased to approximately 90% and 75% of the vehicle control, following TCDD treatment at 5 and 10 μg/kg, respectively (Table 1) .
Induction of CYP1A1 mRNA in the liver and thymus
We determined whether there is any change in the induced level of CYP1A1 mRNA in the liver and thymus from TCDD-exposed L-E, WH GALAS-AhR wt/wt , and WH GALAS-AhR hw/hw -ferences in the CYP1A1 mRNA amounts in both organs (Fig. 3) , indicating that the AhR genotype in the WH GALAS rats does not affect the TCDD-induced CYP1A1 mRNA level. This observation is consistent with the results of a previous study (Tuomisto et al., 1999) .
Effects of AhR variants on rat CYP1A1-promoterand XRE-dependent reporter gene in HeLa cells
On the basis of in vivo data (Fig. 3) , we hypothesized that the transactivational activity for CYP1A1 is not altered by the mutation in AhR, and addressed this problem using four pEB6-CAG-AhR constructs and a reporter plasmid prCYP1A1-Luc cotransfected into HeLa cells.
The transfection of any of the pEB6-CAG-AhR variants activated CYP1A1-promoter-dependent transcriptional activity at similar levels in the absence of TCDD in the medium. This increase was augmented in the presence of TCDD in the medium in a dose-dependent manner for the four AhR variants. For instance, 1 nM TCDD induced a 2.5-fold increase relative to that of the TCDD-free group (Fig. 4) . Thus, no difference was observed among the AhR variants in terms of activation of the CYP1A1 promoter.
We next studied XRE-dependent transcriptional activation potential of the different types of expression promoter connecting AhR variant constructs (pEB6-CAG-AhRs or pCI-AhRs) and the pX4TK-Luc reporter plasmid that were transiently transfected into HeLa cells and exposed with TCDD for 24 hr. There were no statistically significant differences in the XRE-dependent transcriptional activation potential among AhRwt, AhRsiv and AhRliv, but that of AhRdv was 3-fold higher than that of the wild type (Fig. 5A) . Similar data were obtained in the assay using pCI-AhR variants in HeLa cells (Fig. 5B) . These -activates XRE-dependent genes compared with the other AhR variants.
Inhibitory effects of AhR variants on growth of Jurkat T cells
Since the susceptibility of thymic atrophy upon TCDD exposure was strain-dependent as observed between rats having different AhR alleles (Table 1) , we investigated possible roles of AhR variants in cell growth using Jurkat T cells that are not endowed with AhR. The reason why 228 ± 6 219 ± 6 210 ± 4 157 ± 4 154 ± 4 152 ± 3 156 ± 3 152 ± 3 152 ± 3 (100 ± 2) (96 ± 2) (92 ± 2) (100 ± 2) (98 ± 3) (97 ± 2) (100 ± 2) (98 ± 2) (97 ± 2)
Liver weight, g (Liv W/BW, %)
11.3 ± 0. we used Jurkat T cells is that the exogenously introduced constitutively-active AhR suppresses the growth of the cells through apoptosis and cell cycle arrest (Ito et al., 2004) , the observation of which is similar to the one in TCDD-exposed mice in vivo (Kamath et al., 1997; Laiosa et al., 2003) .
We cotransfected pEB6-CAG-hrGFP and either of the four pEB6-AhR variants into Jurkat T cells and incubated them with 10 nM TCDD for 96 hr. The number of Jurkat T cells expressing hr-GFP alone increased approximately 6-fold compared with that at the start of the cell culture. In contrast, the four AhR variants, AhRwt, dv, siv, and liv suppressed cell growth by 42, 67, 50 and 58%, respecfound in the percentage of GFP-positive cells among the AhR variants.
DISCUSSION
The extremely large difference in susceptibility of AhR gene polymorphism. Because the WH GALAS rat has been bred and used worldwide for preclinical examinations of new drugs and for risk assessment of environmental pollutants, the possible effects of the polymorphism in the WH GALAS rat should be evaluated.
WH GALAS rat was found to consist of three populations, Fig. 3 . CYP1A1 mRNA levels in the liver and thymus of L-E, WH GALAS-AhR wt/wt and WH GALAS-AhR hw/hw rats exposed to TCDD. Liver and thymus specimens were collected 168 hr after TCDD (0, 5, and 10 μg/kg) exposure. The CYP1A1 mRNA level in each tissue specimen was determined by real-time RT-PCR and normalized as a ratio to the corresponding cyclophilin (CP) mRNA. Data represent mean ± S.E. for groups of 4 mice. ND; Not Detected. Twenty-four hours after transfection, TCDD was added to the medium, and the cells were harvested 18 hr later in the lysates were normalized using the corresponding internal Renilla luciferase control. Statistically significant differences between means from the WT vector and the other AhR variants were determined by ANOVA followed by Fisher's PLSD test (*P < 0.05). Data are expressed as mean ± S.E. of three independent experiments performed in duplicate. the dioxin-sensitive strain having wild-type AhR (AhR wt/wt ), the dioxin-resistant strain having Han/Wistar (Kuopio)-type AhR (AhR hw/hw ) and the strain having heterogeneous AhR (AhR wt/hw ). Second, there was a considerable difference in susceptibility to TCDD-induced thymic atrophy among the three strains of the WH GALAS rat, and the strain having AhR hw/hw was found to be less sensitive than the strain having AhR wt/wt . Third, there was no difference in the quantities of CYP1A1 mRNA between these two AhR strains. Fourth, the deletion variant of AhR, i.e., AhRdv that lacked 43 amino acid residues in the transactivation domain, had the highest transactivation activity for TCDD in vitro. Fifth, AhR variants showed no difference in their actions on the growth of Jurkat T cells in vitro in contrast to the difference in susceptibility observed for thymic atrophy in vivo among the three rat strains, L-E, WH GALAS-AhR wt/wt , and WH GALAS-AhR hw/hw . To clarify whether and how the AhR structure possibly affects the susceptibility to TCDD toxicities, such as thymic atrophy, among WH GALAS rat strains, we studied the possible effects of the four AhR variants, using their full-length cDNAs, on the activation of the CYP1A1 promoter in the presence of TCDD, the activation of transcription of the synthesized XRE and the growth of Jurkat T cells. We found no difference in CYP1A1 promoter activity among the four AhR variants (Fig. 4) . However, AhRdv was found to have the highest activity mediated by the synthesized XRE among the four AhR variants protein encoded by AhR hw/hw could regulate the XREdependent pathway differently from the proteins encoded by the other AhR variants, which is consistent with the recent data of Moffat and coworkers (Moffat et al., 2007) , who showed, using the transactivation domain of AhR variants and the GAL4-DNA binding domain, that -ity in the absence of exogenous ligands such as TCDD.
It was reported that L-E (Turku A/B) and Han/Wistar (Kuopio) strains show a dose-response pattern for thymic atrophy (Tuomisto et al., 1999) . However, no reports are available on how WH GALAS rat strains having either of the three AhR alleles respond to TCDD to induce thymic atrophy. In the present study, the degree of TCDD-induced thymic atrophy in the WH GALAS strain having AhR hw/hw was found to be less severe than that in the L-E strain and WH GALAS strain having AhR wt/wt , between the L-E strain and WH GALAS strain having AhR wt/wt , suggesting that such a difference in TCDD toxicity to the thymus comes from the functional difference among AhR variant proteins. However, no difference in the transcriptional activation of CYP1A1 was observed among the AhR variants (Fig. 4) , and AhRdv, a splicing variant type of AhR hw/hw , was found to have a markedly high transactivational activity for the synthesized XREdriven reporter. Thus, the difference in structures owing to AhR variants may be minimal to explain the strain difference because the AhR-dependent gene expression mediated by XRE is essential for the onset of TCDD-induced thymic atrophy (Fernandez-Salguero et al., 1996) . However, in future studies, it would be possible to clarify the molecular mechanism of the thymic atrophy in relation to the AhR structure by searching for genes, the expression of which can be altered by a difference in the structure of Besides an XRE-dependent transactivation by AhR, AhR was found to directly interact with proteins, such -fy its function (Ge and Elferink, 1998; Tian et al., 1999; Puga et al., 2000) . The binding of AhR to RB suppresses the transactivation of E2F by inhibiting the dissociation of RB and E2F and induces cell cycle arrest in the G 1 phase (Puga et al., 2000) . In addition, the binding of AhR -et al., 1996; Puga et al., 2000) . The C-terminus of AhR acts as a site to which RB binds (Puga et al., 2000) , but the length of this site differs considerably among the AhR variants of the rat strains. It is thus conjectured that possible differences in the physical interaction between either of the AhR variants and functional proteins induce differences in the susceptibility of thymic atrophy among rat strains. Toxicity mechanisms of the TCDD-elicited thymic atrophy, the cell cycle arrest and apoptosis of thymic T cells have been proposed (Kamath et al., 1997; Laiosa et al., 2003) . To this end, we hypothesized that AhR structural differences are associated with the difference in susceptibility to TCDD-induced thymic atrophy observed in vivo, and studied how AhR variants, i.e., AhRwt, AhRdv, AhRsiv and AhRliv, affect the growth of T cells, by transfecting these AhR variant genes into AhR-null Jurkat T cells. The reason why we used this cell line is three-fold. First, previous studies using knock-out, chimeric and transgenic mice showed that thymic T cells are the main target of TCDD to induce thymic atrophy (Laiosa et al., 2003; Nohara et al., 2005; Staples et al., 1998) . Second, being consistent with the effects of TCDD on T cells in the etiology of thymic atrophy shown in previous in vivo studies (Kamath et al., 1997; Laiosa et al., 2003) , Jurkat T cells having constitutively active AhR showed cell cycle arrest and apoptosis (Ito et al., 2004) . Third, the suppression of the growth of Jurkat T cells having constitutively active AhR has been shown to be caused by both XRE-dependent and XRE-independent mechanisms (Ito et al., 2004) . In contrast to our expectation based on in vivo of Jurkat T cells to the AhR variants although the variants decreased the percentage of GFP-positive cells (Fig.6) . Although TCDD induces thymic atrophy in chimeric mice having AhR +/+ hemopoietic and AhR -/-stroma components, but not in those having AhR -/-hemopoietic and AhR +/+ stroma components (Laiosa et al., 2003; Staples et al., 1998) , it has been reported that TCDD causes several effects on stromal cells, such as aggregation and differentiation of epithelium (De Waal et al., 1992 Greenlee et al., 1985; Kremer et al., 1994) Thus, taken together with the present and previous studies, it is thought that the difference in susceptibility to the thymic atrophy could be explained by the effects of TCDD on cells other than thymic T cells.
The WH GALAS rats used in this study have been bred as a standardized closed colony of laboratory rats by a consortium of major animal breeders in the world to be used for preclinical and risk assessment analyses of various chemicals. AhR is an important transcription factor that plays an essential role in the induction of CYP1A1, CYP1A2 and CYP1B1 that belong to the phase I group of drug-metabolizing enzymes, and this study showed that this WH GALAS rat colony apparently has three AhR alleles, AhR wt/wt , AhR wt/hw , and AhR hw/hw . In our preliminary examinations, we found that even L-E and Sprague-Dawley rat strains occasionally have AhR hw/hw , and thus we suggest that more attention should be paid to the genetic background of the closed colony in toxicological studies.
